Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.258.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.370NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.118NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.137NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.309NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.632NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.72NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.108NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.332NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.42.1 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
A.23NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.596.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.473NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.595.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.76.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BA.2.38.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BM.4NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.357NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BP.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.214NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.284NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.351.3 (Beta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.318NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
R.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AY.29 (Delta)NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
ML.1NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.283NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
BE.12NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.145NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.547NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.247NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.205NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.110NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.434NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.4.5NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.181NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.6.6NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.37NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.1.513NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.338NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.284NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.9.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.498NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.184NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
B.1.187NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
D.3NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
AE.2NWon-NCAATGCTGCAATCGTGCTAC20502873228751F-22388.1South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used